JP2010533478A5 - - Google Patents

Download PDF

Info

Publication number
JP2010533478A5
JP2010533478A5 JP2010516305A JP2010516305A JP2010533478A5 JP 2010533478 A5 JP2010533478 A5 JP 2010533478A5 JP 2010516305 A JP2010516305 A JP 2010516305A JP 2010516305 A JP2010516305 A JP 2010516305A JP 2010533478 A5 JP2010533478 A5 JP 2010533478A5
Authority
JP
Japan
Prior art keywords
gamma secretase
seq
ledaefrhds
lvml
substrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010516305A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010533478A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from US12/172,978 external-priority patent/US20090023158A1/en
Publication of JP2010533478A publication Critical patent/JP2010533478A/ja
Publication of JP2010533478A5 publication Critical patent/JP2010533478A5/ja
Withdrawn legal-status Critical Current

Links

JP2010516305A 2007-07-13 2008-07-14 ガンマセクレターゼの阻害剤の基質特異性を同定するための組成物および方法 Withdrawn JP2010533478A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94973807P 2007-07-13 2007-07-13
US12/172,978 US20090023158A1 (en) 2007-07-13 2008-07-14 Compositions and Methods for Identifying Substrate Specificity of Inhibitors of Gamma Secretase
PCT/US2008/070012 WO2009012237A1 (en) 2007-07-13 2008-07-14 Compositions and methods for identifying substrate specificity of inhibitors of gamma secretase

Publications (2)

Publication Number Publication Date
JP2010533478A JP2010533478A (ja) 2010-10-28
JP2010533478A5 true JP2010533478A5 (cg-RX-API-DMAC7.html) 2011-09-01

Family

ID=39739883

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010516305A Withdrawn JP2010533478A (ja) 2007-07-13 2008-07-14 ガンマセクレターゼの阻害剤の基質特異性を同定するための組成物および方法

Country Status (5)

Country Link
US (2) US20090023158A1 (cg-RX-API-DMAC7.html)
EP (1) EP2183598A1 (cg-RX-API-DMAC7.html)
JP (1) JP2010533478A (cg-RX-API-DMAC7.html)
CA (1) CA2692604A1 (cg-RX-API-DMAC7.html)
WO (1) WO2009012237A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2166110B1 (en) * 2007-06-08 2012-02-22 Eisai R&D Management Co., Ltd. Screening method utilizing novel substrate epha4 for gamma-secretase
JPWO2009011426A1 (ja) * 2007-07-19 2010-09-24 エーザイ・アール・アンド・ディー・マネジメント株式会社 γ−セクレターゼの新規基質c−Metを利用したスクリーニング方法
JPWO2009017234A1 (ja) * 2007-08-01 2010-10-28 エーザイ・アール・アンド・ディー・マネジメント株式会社 γ−セクレターゼの新規基質c−Retを利用したスクリーニング方法
US20090163594A1 (en) * 2007-10-31 2009-06-25 Elan Pharmaceuticals, Inc. Triple Assay System for Identifying Substrate Selectivity of Gamma Secretase Inhibitors
EP2219028B1 (en) * 2007-11-15 2012-09-12 Eisai R&D Management Co., Ltd. Screening method utilizing novel substrate epha7 for gamma-secretase
DK2223999T3 (en) * 2007-11-30 2017-12-18 Eisai R&D Man Co Ltd EPHA4 POLYPEPTIDE WITH UNKNOWN ACTIVITY AND USE THEREOF
EP2653552B1 (en) 2010-12-17 2016-10-19 Eisai R&D Management Co., Ltd. SCREENING METHOD USING GELATINASE-MEDIATED EphA4 CLEAVAGE REACTION AS AN INDICATOR
EP2703814B1 (en) 2011-04-25 2017-11-01 Eisai R&D Management Co., Ltd. Method for detecting neurological disease associated with cognitive dysfunction by measuring epha4 extracellular domain
RU2627177C2 (ru) 2012-06-22 2017-08-03 Джентиум С.Р.Л. Способ определения биологической активности дефибротида, основанный на применении эуглобулина
EP3026122A1 (en) * 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
EP3759127A4 (en) * 2018-03-02 2022-03-30 Ionis Pharmaceuticals, Inc. COMPOUNDS AND METHODS FOR MODULATING AMYLOID BETA PRECURSOR PROTEIN
CA3139398A1 (en) 2019-07-01 2021-01-07 Eisai R&D Management Co., Ltd. Anti-epha4 antibody
WO2021174075A1 (en) * 2020-02-27 2021-09-02 Adeptrix Corp. Multiplexed bead-based analytical assays
WO2021206910A1 (en) * 2020-04-09 2021-10-14 The Regents Of The University Of California Notch receptors with zinc finger-containing transcriptional effector
KR20230043914A (ko) 2020-07-28 2023-03-31 아이오니스 파마수티컬즈, 인코포레이티드 App 발현을 감소시키기 위한 화합물 및 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5441870A (en) 1992-04-15 1995-08-15 Athena Neurosciences, Inc. Methods for monitoring cellular processing of β-amyloid precursor protein
US5604102A (en) * 1992-04-15 1997-02-18 Athena Neurosciences, Inc. Methods of screening for β-amyloid peptide production inhibitors
US5766846A (en) * 1992-07-10 1998-06-16 Athena Neurosciences Methods of screening for compounds which inhibit soluble β-amyloid peptide production
US5605811A (en) * 1992-10-26 1997-02-25 Athena Neurosciences, Inc. Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein
AU702293B2 (en) 1993-10-27 1999-02-18 Athena Neurosciences, Inc. Transgenic animals harboring APP allele having Swedish mutation
DE10131899A1 (de) * 2001-07-04 2003-02-27 Boehringer Ingelheim Pharma In vitro-Screening-Assay für gamma-Secretase
WO2007058987A1 (en) * 2005-11-10 2007-05-24 Bristol-Myers Squibb Company Methods of identifying compounds that inhibit notch cleavage
US20090163594A1 (en) * 2007-10-31 2009-06-25 Elan Pharmaceuticals, Inc. Triple Assay System for Identifying Substrate Selectivity of Gamma Secretase Inhibitors

Similar Documents

Publication Publication Date Title
JP2010533478A5 (cg-RX-API-DMAC7.html)
JP2013503110A5 (cg-RX-API-DMAC7.html)
JP2008237210A5 (cg-RX-API-DMAC7.html)
WO2010123290A3 (ko) 체내 지속성을 유지함으로 체내 반감기가 증가된 단백질 또는 펩티드 융합체, 및 이를 이용하여 체내 반감기를 증가시키는 방법
MY153198A (en) Inhibitors of protein aggregation
WO2011022667A3 (en) Catalytic domains from lysyl oxidase and loxl2
WO2017070256A8 (en) Method for screening inhibitors of ras
WO2012082056A8 (en) Novel biomarker and uses thereof in diagnosis, treatment of autism
JP2013539454A5 (cg-RX-API-DMAC7.html)
WO2009129311A3 (en) Somatostatin receptor 2 antagonists
WO2007148224A8 (en) Polypeptide
NZ597692A (en) Anti-IGF antibodies
JP2008536483A5 (cg-RX-API-DMAC7.html)
IL178515A0 (en) Oligopeptides for reducing elevated blood urea concentration
JP2013505287A5 (cg-RX-API-DMAC7.html)
JP2021505620A5 (cg-RX-API-DMAC7.html)
WO2009024327A3 (en) New proteins for use in human and animal staphylococcus infections
JP2016513471A5 (cg-RX-API-DMAC7.html)
WO2005119251A3 (en) Novel means and methods for the treatment of hearing loss and phantom hearing
JP2009527503A5 (cg-RX-API-DMAC7.html)
WO2018175581A8 (en) A GENETICALLY MODIFIED MOUSE EXPRESSING HUMAN APOE4 AND MOUSE Trem2 p.R47H AND METHODS OF USE THEREOF
JP2005512547A5 (cg-RX-API-DMAC7.html)
ATE488252T1 (de) Erhöhte transduktion mit abc- transportersubstratenhemmern
JP2014534173A5 (cg-RX-API-DMAC7.html)
WO2008126783A1 (ja) ジペプチドの製造法